Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 14/20 | 0.49 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20002855 | 0.93 | MAPT (0.47) | RORCCYP2C8L3MBTL1MAPTHTR2A | |
| SCHEMBL20002731 | 0.89 | L3MBTL1 (0.48) | RORCL3MBTL1HTR2AHTR2CKCNH2 | |
| SCHEMBL20002381 | 0.89 | L3MBTL1 (0.56) | RORCL3MBTL1MAPTEPHX2 | |
| SCHEMBL20002434 | 0.89 | L3MBTL1 (0.56) | RORCL3MBTL1MAPTEPHX2 | |
| SCHEMBL20002459 | 0.88 | RORC (0.51) | RORCMAPTHTR2AHTR2CKCNH2 | |
| SCHEMBL20002743 | 0.86 | L3MBTL1 (0.48) | RORCL3MBTL1MAPTHTR2AHTR2C | |
| SCHEMBL20003057 | 0.86 | RORC (0.50) | RORCL3MBTL1MAPTHTR2AHTR2C | |
| SCHEMBL20002254 | 0.86 | L3MBTL1 (0.48) | RORCL3MBTL1HTR2AHTR2CKCNH2 | |
| SCHEMBL20002251 | 0.86 | RORC (0.52) | RORCL3MBTL1 | |
| SCHEMBL20002684 | 0.85 | L3MBTL1 (0.47) | RORCL3MBTL1MAPTHTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3092229-B1 | PYRROLIDINYL SULFONE DERIVATIVES AND THEIR USE AS ROR GAMMA MODULATORS | BRISTOL MYERS SQUIBB CO (US) | 2018-03-28 | — | — | EP | disclosed |